InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（59 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
59
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Azamian Bobak R., 首席执行官. Officer active across 1 company, notably Tarsus Pharmaceuticals, Inc.. Cumulatively, 63 disclosures have been logged. Breakdown: 0 buy · 59 sells. Total volume traded: €7.7m. Activity tracked since 5 August 2021. The latest transaction was disclosed on 4 September 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Azamian Bobak R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报63 总计
7,100 股@ US$90.27Common StockSEC:0001827672-26-000013:0
2,900 股@ US$91.27Common StockSEC:0001827672-26-000013:1
10,000 股@ US$80.060.026% mcap10.0% 占其流量Common StockSEC:0001827672-26-000011:0
4,582 股Common StockSEC:0001827672-26-000009:0
5,418 股Common StockSEC:0001827672-26-000009:1
10,972 股@ US$69.4211.2% 占其流量Common StockSEC:0001827672-26-000007:0
66,274 股Common StockSEC:0001827672-26-000005:0
557 股@ US$83.540.7% 占其流量Common StockSEC:0001827672-25-000007:1
5,443 股@ US$82.417.1% 占其流量Common StockSEC:0001827672-25-000007:0
51,885 股0Common StockSEC:0001827672-25-000005:0
6,000 股@ US$55.374.6% 占其流量Common StockSEC:0001827672-25-000003:0
6,000 股@ US$50.004.4% 占其流量Common StockSEC:0001819790-25-000110:0
6,000 股@ US$50.005.1% 占其流量Common StockSEC:0001819790-25-000061:0
7,131 股@ US$46.295.6% 占其流量Common StockSEC:0001819790-25-000055:0
51,395 股Common StockSEC:0001819790-25-000046:0
28,274 股Common StockSEC:0001819790-24-000045:0
8,000 股@ US$20.222.7% 占其流量Common StockSEC:0001827672-23-000050:0
9,443 股@ US$19.963.2% 占其流量Common StockSEC:0001827672-23-000048:0
2,896 股@ US$18.010.9% 占其流量Common StockSEC:0001827672-23-000045:0
8,000 股@ US$13.241.9% 占其流量Common StockSEC:0001827672-23-000043:0
8,000 股@ US$17.213.3% 占其流量Common StockSEC:0001827672-23-000041:0
8,000 股@ US$17.232.4% 占其流量Common StockSEC:0001827672-23-000039:0
4,174 股@ US$19.281.3% 占其流量Common StockSEC:0001827672-23-000037:0
9,000 股@ US$17.352.6% 占其流量Common StockSEC:0001827672-23-000035:0
8,000 股@ US$18.632.5% 占其流量Common StockSEC:0001819790-23-000048:0
63 条申报中的 25 条
About Azamian Bobak R.
Azamian Bobak R. is Directeur Général and is linked to Tarsus Pharmaceuticals, Inc., where he holds the role of President/CEO and Board Chair. He has 60 filings in total, and across the 60 sampled filings, they cover sales between 2021-08-06 and 2026-06-22, for a total of EUR 6196570 in sales and EUR 0 in purchases.
